JO3676B1 - مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها - Google Patents
مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بهاInfo
- Publication number
- JO3676B1 JO3676B1 JOP/2010/0261A JOP20100261A JO3676B1 JO 3676 B1 JO3676 B1 JO 3676B1 JO P20100261 A JOP20100261 A JO P20100261A JO 3676 B1 JO3676 B1 JO 3676B1
- Authority
- JO
- Jordan
- Prior art keywords
- methods relating
- pharmaceutical compositions
- modified fucans
- fucans
- modified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
يتعلق الاختراع الحالي بتركيبات وطرق تتعلق بعوامل الفيوكان المفيدة في علاج الالتصاقات الليفية أو الأمراض الأخرى والوقاية منها وتثبيطها...الخ.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22892909P | 2009-07-27 | 2009-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3676B1 true JO3676B1 (ar) | 2020-08-27 |
Family
ID=43497856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2010/0261A JO3676B1 (ar) | 2009-07-27 | 2010-07-25 | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
Country Status (19)
Country | Link |
---|---|
US (6) | US8466125B2 (ar) |
EP (2) | EP3300737A1 (ar) |
JP (5) | JP2013500274A (ar) |
KR (1) | KR20120083297A (ar) |
CN (2) | CN102665733B (ar) |
AR (1) | AR078082A1 (ar) |
AU (4) | AU2010278640A1 (ar) |
BR (1) | BR112012008072A2 (ar) |
CA (2) | CA2769147A1 (ar) |
CL (1) | CL2012000215A1 (ar) |
EA (1) | EA201270186A1 (ar) |
IN (1) | IN2012DN01314A (ar) |
JO (1) | JO3676B1 (ar) |
MX (1) | MX2012001212A (ar) |
MY (1) | MY168759A (ar) |
SG (3) | SG177741A1 (ar) |
TW (2) | TWI569801B (ar) |
WO (1) | WO2011011881A1 (ar) |
ZA (1) | ZA201200999B (ar) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1809303B1 (en) * | 2004-09-23 | 2019-03-06 | ARC Medical Devices, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
JO3676B1 (ar) * | 2009-07-27 | 2020-08-27 | Arc Medical Devices Inc | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
JP2013521300A (ja) * | 2010-03-03 | 2013-06-10 | ネオキュティス エスアー | 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法 |
FR2984126B1 (fr) * | 2011-12-20 | 2014-08-22 | Oreal | Polysaccharides sulfates agent antipelliculaire |
CN107580497A (zh) * | 2015-02-16 | 2018-01-12 | 克桑蒂亚尔 | 用于预防或治疗皮肤病症的组合物 |
CN105663154B (zh) * | 2016-01-18 | 2020-06-30 | 首都医科大学 | 褐藻多糖硫酸酯在制备预防和/或治疗下肢外周动脉血管病的产品中的应用 |
US20180056087A1 (en) * | 2016-08-26 | 2018-03-01 | Adolfo Ribeiro | Wearable Micro-LED Healing Bandage |
CN106943619A (zh) * | 2017-03-17 | 2017-07-14 | 清华大学 | 一种液体伤口敷料及其制备方法 |
US11642368B2 (en) | 2018-07-27 | 2023-05-09 | ARC Medical Inc. | Highly purified and/or modified fucan compositions for the treatment of fibrous adhesions |
CN115260328A (zh) * | 2022-08-14 | 2022-11-01 | 湘潭大学 | 一种改性岩藻多糖化合物及其制备方法和应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
IT1288713B1 (it) * | 1996-12-18 | 1998-09-23 | Crinos Industria Farmaco | Fucani a basso peso molecolare aventi attivita' anticoagulante antitrombinica e antitrombotica |
FR2772618B1 (fr) * | 1997-12-18 | 2000-02-18 | Ifremer | Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs |
KR100675541B1 (ko) * | 1999-08-20 | 2007-01-29 | 다카라 바이오 가부시키가이샤 | 치료제 |
US6812220B2 (en) * | 2001-08-29 | 2004-11-02 | University Of British Columbia | Pharmaceutical compositions and methods relating to fucans |
NO320671B1 (no) * | 2001-11-30 | 2006-01-16 | Fmc Biopolymer As | Fremgangsmate for a stimulere vektokning i fisk. |
AU2004243513A1 (en) * | 2003-05-30 | 2004-12-09 | Arc Pharmaceuticals, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents |
CN1829501A (zh) * | 2003-05-30 | 2006-09-06 | Arc药品有限公司 | 涉及使用多种药物抑制纤维粘连的药用组合物和方法 |
EP1809303B1 (en) | 2004-09-23 | 2019-03-06 | ARC Medical Devices, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
US8426381B2 (en) * | 2005-09-09 | 2013-04-23 | Lucas Meyer Cosmetics Canada Inc. | Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation |
CN1935154A (zh) * | 2006-09-04 | 2007-03-28 | 北京世纪博康医药科技有限公司 | 褐藻多糖硫酸酯在制备治疗心脑血管疾病的药物中的用途 |
EP2121767B1 (en) * | 2007-02-23 | 2014-04-09 | Baxter International Inc. | Process methods for fucoidan purification from seaweed extracts |
GB0707096D0 (en) * | 2007-04-12 | 2007-05-23 | Ntnu Technology Transfer As | Method |
JO3676B1 (ar) * | 2009-07-27 | 2020-08-27 | Arc Medical Devices Inc | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
-
2010
- 2010-07-25 JO JOP/2010/0261A patent/JO3676B1/ar active
- 2010-07-26 TW TW104117619A patent/TWI569801B/zh not_active IP Right Cessation
- 2010-07-26 TW TW099124495A patent/TWI491396B/zh active
- 2010-07-27 MX MX2012001212A patent/MX2012001212A/es active IP Right Grant
- 2010-07-27 AR ARP100102706A patent/AR078082A1/es not_active Application Discontinuation
- 2010-07-27 CN CN201080042840.4A patent/CN102665733B/zh active Active
- 2010-07-27 CA CA2769147A patent/CA2769147A1/en not_active Abandoned
- 2010-07-27 CA CA3046665A patent/CA3046665C/en active Active
- 2010-07-27 BR BR112012008072A patent/BR112012008072A2/pt not_active Application Discontinuation
- 2010-07-27 EP EP17193478.9A patent/EP3300737A1/en active Pending
- 2010-07-27 KR KR1020127004988A patent/KR20120083297A/ko not_active Application Discontinuation
- 2010-07-27 SG SG2012005104A patent/SG177741A1/en unknown
- 2010-07-27 EP EP10803778A patent/EP2459200A4/en not_active Ceased
- 2010-07-27 EA EA201270186A patent/EA201270186A1/ru unknown
- 2010-07-27 SG SG10201808960VA patent/SG10201808960VA/en unknown
- 2010-07-27 CN CN201610545789.8A patent/CN106176798A/zh active Pending
- 2010-07-27 WO PCT/CA2010/001175 patent/WO2011011881A1/en active Application Filing
- 2010-07-27 US US12/843,992 patent/US8466125B2/en active Active
- 2010-07-27 SG SG10201401436VA patent/SG10201401436VA/en unknown
- 2010-07-27 MY MYPI2012000343A patent/MY168759A/en unknown
- 2010-07-27 AU AU2010278640A patent/AU2010278640A1/en not_active Abandoned
- 2010-07-27 JP JP2012521918A patent/JP2013500274A/ja active Pending
-
2012
- 2012-01-26 CL CL2012000215A patent/CL2012000215A1/es unknown
- 2012-02-10 ZA ZA2012/00999A patent/ZA201200999B/en unknown
- 2012-02-13 IN IN1314DEN2012 patent/IN2012DN01314A/en unknown
-
2013
- 2013-06-14 US US13/918,544 patent/US20140128340A1/en not_active Abandoned
-
2014
- 2014-05-27 US US14/287,307 patent/US20140274942A1/en not_active Abandoned
-
2016
- 2016-02-04 JP JP2016019894A patent/JP2016128491A/ja active Pending
- 2016-08-24 AU AU2016219615A patent/AU2016219615A1/en not_active Abandoned
- 2016-09-22 US US15/272,949 patent/US20180051097A1/en not_active Abandoned
-
2017
- 2017-07-03 JP JP2017130195A patent/JP2017206542A/ja active Pending
- 2017-09-27 US US15/717,681 patent/US20180230240A1/en not_active Abandoned
-
2018
- 2018-05-16 AU AU2018203461A patent/AU2018203461A1/en not_active Abandoned
-
2019
- 2019-04-03 JP JP2019071611A patent/JP2019142896A/ja active Pending
- 2019-05-17 US US16/415,397 patent/US20200115472A1/en not_active Abandoned
- 2019-11-20 AU AU2019268096A patent/AU2019268096A1/en not_active Abandoned
-
2020
- 2020-09-30 JP JP2020164770A patent/JP2021020907A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO3676B1 (ar) | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها | |
MX336381B (es) | Boronatos como inhibidores de arginasa. | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
IN2012DN00971A (ar) | ||
MY198422A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
IN2012DN02805A (ar) | ||
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
TN2012000081A1 (en) | Compounds and compositions as protein kinase inhibitors | |
MX2009009491A (es) | Compuestos y composiciones como moduladores de la actividad del gpr119. | |
EP2477985A4 (en) | CANCER TREATMENT | |
EP2493464A4 (en) | METHYLSULFONYLMETHANE (MSM) FOR THE TREATMENT OF DRUG-RESISTANT MICROORGANISMS | |
MA33803B1 (ar) | مثبط برومودومين البنزوديازيبين | |
MX351464B (es) | El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas. | |
MX2009006706A (es) | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. | |
MX2009007944A (es) | Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium. | |
IN2012DN02471A (ar) | ||
IN2012DN01233A (ar) | ||
IN2012DN00624A (ar) | ||
MX2011009539A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso. | |
MY161495A (en) | Virus like particle compositions and methods of use | |
DE602007010764D1 (en) | Benzamidglucokinaseaktivatoren | |
MX2011013032A (es) | Inhibidores de fosfatidilinositol 3-cinasa. | |
MX2010002734A (es) | Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva. | |
MX2012001134A (es) | Composiciones y metodos para inhibicion de la via jak. | |
MY167898A (en) | Co-crystals and salts of ccr3-inhibitors |